Pharmaceuticals

Global Anthelmintic Drugs Market Report 2026: Emerging Trends and Growth Scenarios

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the anthelmintic drugs market from 2026–2035 with trusted insights from The Business Research Company

How much is the Anthelmintic Drugs Market valued at in 2026, and what valuation is forecast for 2030?

The anthelmintic drugs market size has shown robust growth over recent years. It is anticipated to increase from $3.34 billion in 2025 to $3.53 billion in 2026, registering a compound annual growth rate (CAGR) of 5.5%. The expansion witnessed in the past can be attributed to the high prevalence of parasitic infections, restricted access to advanced anthelmintic drugs, continued reliance on traditional drug classes, increasing awareness concerning helminth infections, and the growing infrastructure of hospitals and clinics.

The anthelmintic drugs market size is expected to undergo substantial growth in the upcoming years. It is forecast to expand to $4.32 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 5.2%.

This anticipated growth within the forecast period is due to factors such as the development of innovative anthelmintic compounds, the growing use of combination therapies, an increase in veterinary and livestock applications, the widening reach of online and retail pharmacy channels, and government efforts in parasite control programs.

Major trends identified for the forecast period include the increasing prevalence of helminth infections in both human and animal populations, the rising adoption of oral anthelmintics and injectable formulations, greater demand for veterinary anthelmintics in livestock management, the expansion of retail and online pharmacy channels for anthelmintic drugs, and a strong focus on combination therapies and broad-spectrum anthelmintics.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19291&type=smp

What Drivers Are Influencing The Growth Of The Anthelmintic Drugs Market?

The widespread occurrence of parasitic infections is anticipated to propel the growth of the anthelmintic drugs market going forward. Parasitic infections are illnesses caused by organisms such as protozoa, worms, or ectoparasites that reside on or within a host. These infections are primarily fueled by poor sanitation, contaminated food or water, close contact with infected individuals or animals, inadequate hygiene, and a lack of access to clean resources. Anthelmintic drugs are utilized to treat infections caused by parasitic worms, effectively targeting and eliminating these parasites from the host’s body. These medications function by disrupting the parasites’ physiological processes, leading to their expulsion or death. For instance, in September 2025, data published by the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that as of September 16, 2025, the CDC had recorded 990 cases of cyclosporiasis acquired in the United States. Consequently, the high prevalence of parasitic infections is a key factor driving the expansion of the anthelmintic drugs market.

How Is The Anthelmintic Drugs Market Organized Into Various Segments?

The anthelmintic drugs market covered in this report is segmented –

1) By Drug Class: Benzimidazoles, Macrocyclic lactones, Pyrazinoisoquinolones, Tetrahydropyrimidines, Other Drug Classes

2) By Route Of Administration: Oral, Injectable

3) By Infection Type: Nematode Infections, Cestode Infections, Trematode Infections, Mixed Infections

4) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics And Supply Stores

5) By Application: Human Anthelmintics, Veterinary Anthelmintics

Subsegments:

1) By Benzimidazoles: Albendazole, Mebendazole, Fenbendazole, Oxfendazole, Thiabendazole

2) By Macrocyclic Lactones: Ivermectin, Moxidectin, Doramectin, Eprinomectin, Milbemycin Oxime

3) By Pyrazinoisoquinolones: Praziquantel, Cysticide

4) By Tetrahydropyrimidines: Pyrantel Pamoate, Pyrantel Tartrate

5) By Other Drug Classes: Imidazothiazoles, Aminoacetonitrile Derivatives, Spiroindoles, Arsenicals

What Upcoming Trends Are Likely To Define The Future Path Of The Anthelmintic Drugs Market?

Major companies operating in the anthelmintic drugs market are concentrating on creating novel solutions, such as precision, evidence-informed deworming initiatives, to enhance parasite management, mitigate drug resistance, and foster the sustainable application of anthelmintics, contrasting with conventional broad-spectrum deworming methods characterized by frequent, non-specific treatments. These precise deworming strategies utilize diagnostic evaluations, assessments of parasite burden, and deliberate dosing regimens to maximize treatment effectiveness, concurrently diminishing environmental and resistance-related hazards. A notable example is in April 2025, when Zoetis Inc., a US-based animal health enterprise, introduced the “Buy Less Dewormer” campaign aimed at equine populations, advocating for parasite management founded on evidence. This initiative integrates educational content with advice on monitoring fecal egg counts and selecting anthelmintics judiciously; its operation centers on motivating horse owners and veterinarians to apply treatments solely when required, determined by the parasite load and a risk evaluation. Distinctive attributes encompass integrated educational resources, recommendations for risk-driven treatment, and backing for responsible anthelmintic management; its applications extend to managing the health of equine herds, preventing the emergence of parasite resistance, and refining deworming timetables. The advantages comprise a reduction in anthelmintic overuse, enhanced results in parasite control, decreased expenditures for owners, and the fostering of enduring drug effectiveness.

Who Are The Prominent Global Companies Shaping The Anthelmintic Drugs Market Landscape?

Major companies operating in the anthelmintic drugs market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Limited, Zoetis Inc., Hetero Labs Limited, Sun Pharmaceutical Industries Ltd., Galderma S.A., Cipla Inc., Ferring Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Ltd., Mankind Pharma Ltd., Reese Pharmaceutical Company

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Anthelmintic Drugs Market?

North America was the largest region in the anthelmintic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthelmintic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Anthelmintic Drugs Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19291&type=smp

Browse Through More Reports Similar to the Global Anthelmintic Drugs Market 2026, By The Business Research Company

Kidney Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report

Prostate Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

Ovarian Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/ovarian-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795